In orthopedic M&A, one audacious open letter stands as a masterclass in disruption.
Back in 2003, Smith & Nephew had seemingly sealed the fate of Swiss giant Centerpulse with a meticulously negotiated acquisition—boards aligned, terms set, and closure imminent.
But in a stunning overnight reversal that still echoes through boardrooms today, Zimmer's chairman unleashed a persuasive missile: a public missive offering a jaw-dropping 19% premium, blending strategic flattery, financial muscle, and unyielding confidence to snatch victory from the jaws of defeat.
This is the story of the l...
